By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BrainCells Inc. 

10835 Road To The Cure
Suite 150
San Diego  California  92121  U.S.A.
Phone: 858-812-7700 Fax: 858-812-7630



Company News
BrainCells Inc. Announces the Successful Completion of the Single Ascending Dose Study With BCI-838 and the Initiation of the Multiple Ascending Dose Study 2/29/2012 11:30:04 AM
BrainCells Inc. Grabs Neuropsych Therapy from Proximagen Group in $51M Licensing Pact 8/4/2010 8:10:28 AM
BrainCells Inc. Issued First U.S. Patent for Drug Combinations That Modulate Neurogenesis 4/29/2010 8:09:16 AM
BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman 10/20/2009 11:06:22 AM
Unlikely Treatment Identified by BrainCells Inc. Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 7/27/2009 9:10:55 AM
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer 3/30/2009 8:22:57 AM
BrainCells Inc. Appoints David E. Thompson to Its Board of Directors 12/3/2008 9:02:43 AM
BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety 4/17/2008 4:35:45 PM
BrainCells Inc. Expands Series B Financing to $50 Million 4/17/2008 4:32:01 PM
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing 3/10/2008 7:17:59 AM